InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

FENNEC PHARMACEUTICALS INC.

FENC Clue Score47
United States Fiscal year ends December CIK 0001211583 Results filed 24 Mar 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

25
Insider
Date
Role
Action
Shares
Price
Amount
Marco Maria Brughera
15 Sep 2026
Director
Sold after exercise
15,545
$10.29
$159.96K
Rosty Raykov
1 Sep 2026
Former Director
Sold on a plan
10,000
$12.11
$121.10K
Pierre Sargis Sayad
31 Aug 2026
Chief Medical Officer
Sell
12,000
$12.18
$146.16K
Robert Andrade
28 Aug 2026
Chief Financial Officer
Exercised, kept
21,928
$5.10
$111.83K
Robert Andrade
27 Aug 2026
Chief Financial Officer
Sold on a plan
75,000
$11.78
$883.50K
Rosty Raykov
3 Aug 2026
Former Director
Sold on a plan
10,000
$9.58
$95.80K
Rosty Raykov
1 Jul 2026
Former Director
Sold after exercise
9,599
$10.41
$99.93K
Rosty Raykov
1 Jun 2026
Director
Sold after exercise
9,747
$9.62
$93.77K
Chris A Rallis
11 May 2026
Director
Sold after exercise
8,346
$7.04
$58.76K
Rosty Raykov
1 May 2026
Director
Sold after exercise
10,781
$6.47
$69.75K
Rosty Raykov
1 Apr 2026
Director
Sold after exercise
10,946
$6.31
$69.07K
Christiana Marie Cioffi
26 Mar 2026
Chief Strategy Officer
Exercised, kept
4,700
$4.23
$19.88K
Robert Andrade
26 Mar 2026
Chief Financial Officer
Exercised, kept
13,072
$5.10
$66.67K
Rosty Raykov
2 Mar 2026
Director
Sold after exercise
10,079
$8.36
$84.26K
Robert Andrade
18 Feb 2026
Chief Financial Officer
Exercised, kept
2,450
$4.08
$10.00K
Rosty Raykov
2 Feb 2026
Director
Sold after exercise
10,349
$7.76
$80.31K
Robert Andrade
23 Jan 2026
Chief Financial Officer
Exercised, kept
10,000
$2.45
$24.50K
Robert Andrade
15 Jan 2026
Chief Financial Officer
Exercised, kept
10,000
$2.45
$24.50K
Robert Andrade
7 Jan 2026
Chief Financial Officer
Exercised, kept
14,184
$2.45
$34.75K
Rosty Raykov
2 Jan 2026
Director
Sold after exercise
10,312
$7.60
$78.37K
Southpoint Capital Advisors LP
24 Dec 2025
10% owner
Sell indirect
1,000,000
$7.50
$7.50M
Rosty Raykov
5 Dec 2025
Director
Sold on a plan
10,000
$7.54
$75.40K
Southpoint Capital Advisors LP
18 Nov 2025
10% owner
Sell indirect
19,341
$8.79
$170.05K
Southpoint Capital Advisors LP
17 Nov 2025
10% owner
Sell indirect
85,918
$8.79
$755.19K
Southpoint Capital Advisors LP
14 Nov 2025
10% owner
Sell indirect
160,100
$8.00
$1.28M

What was left out

Form 4 filings counted 79
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 9
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 464,085
History held since 2 May 2007